好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognitive Limitations after Hemorrhagic Stroke are Related to Anxiety
Cerebrovascular Disease and Interventional Neurology
P7 - Poster Session 7 (5:00 PM-6:00 PM)
14-013
The objective of this study was to determine the relationship between cognitive, psychiatric, and functional outcomes 3 months after hemorrhagic stroke.
Hemorrhagic stroke may cause cognitive limitations. Studying the association between cognition, psychiatric outcomes, and functional status after hemorrhagic stroke may improve understanding of cognition in this patient population.
Patients with non-traumatic intracerebral or subarachnoid hemorrhage (ICH or SAH) admitted at an urban academic medical center between January 2015 and January 2024 were assessed by telephone 3 months after discharge using the Quality of Life in Neurological Disorders (Neuro-QoL) Cognitive Function, Anxiety, Depression, and Sleep Disturbance short forms, as well as the modified Rankin Scale (mRS). Univariate and multivariate analysis were used to evaluate the relationship between poor cognition (Neuro-QoL t-score ≤ 50) and functional status and psychiatric comorbidities in 1) patients with ICH or SAH and 2) patients with ICH.
Of 101 patients (62 ICH and 39 SAH), there were 51 (50%) with poor cognition 3-months post-bleed, 60 (61%) with mRS score 3-5, 43 (43%) with anxiety, 28 (28%) with depression, and 30 (31%) with sleep disturbance. On univariate analysis of the full cohort, poor cognition was associated with (p<0.05) anxiety, depression, sleep disturbance, and mRS score 3-5. On multivariate analysis, poor cognition was associated with anxiety (OR 4.38, 95% CI 1.3-14.7, p = 0.017) and mRS score 3-5 (OR 6.15, 95% CI 1.96-19.3, p = 0.002). On univariate analysis of the 62 patients with ICH, poor cognition was associated with (p<0.05) anxiety, sleep disturbance, and mRS score 3-5. On multivariate analysis, poor cognition was associated with anxiety (OR 10.98, 95% CI 2.3-52, p = 0.003).
Poor cognition is associated with anxiety 3 months after hemorrhagic stroke. Additional research is needed to understand whether treatment of anxiety would improve cognition in this patient population.
Authors/Disclosures
Saami Zakaria, MD
PRESENTER 		Dr. Zakaria has nothing to disclose.
Hamza Ahmed, student Mr. Ahmed has nothing to disclose.
Kara R. Melmed, MD (NYU Langone Neurology Associates) Dr. Melmed has nothing to disclose.
Benjamin Brush, MD (NYU Langone Neurology) Dr. Brush has nothing to disclose.
Aaron Lord, MD (NYU Langone-Brooklyn) Dr. Lord has nothing to disclose.
Lindsey Gurin, MD (Langone Orthopedic Hospital) Dr. Gurin has received personal compensation in the range of $0-$499 for serving as a physician reviewer with Healthcare Quality Strategies, Inc. Dr. Gurin has received personal compensation in the range of $500-$4,999 for serving as a consultant with Human Services Research Institute.
Jennifer A. Frontera, MD (NYU Langone Health) Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician 好色先生 Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Koto Ishida, MD, FAAN (NYU) Dr. Ishida has received publishing royalties from a publication relating to health care.
Jose L. Torres, MD (NYU) Dr. Torres has nothing to disclose.
Cen Zhang, MD Dr. Zhang has nothing to disclose.
Leah P. Dickstein, MD (Johns Hopkins Hospital) Dr. Dickstein has nothing to disclose.
David E. Kahn, MD (NYU School of Medicine) An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Ting Zhou, MD (New York University Langone Health - Brooklyn) Dr. Zhou has nothing to disclose.
Ariane Lewis, MD, FAAN (NYU Langone Medical Center) Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.